Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning - PubMed
. 2013 Aug;228(4):481-91.
doi: 10.1007/s00221-013-3579-0. Epub 2013 Jun 2.
Affiliations
- PMID: 23727882
- DOI: 10.1007/s00221-013-3579-0
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J Catlow et al. Exp Brain Res. 2013 Aug.
Abstract
Drugs that modulate serotonin (5-HT) synaptic concentrations impact neurogenesis and hippocampal (HPC)-dependent learning. The primary objective is to determine the extent to which psilocybin (PSOP) modulates neurogenesis and thereby affects acquisition and extinction of HPC-dependent trace fear conditioning. PSOP, the 5-HT2A agonist 25I-NBMeO and the 5-HT2A/C antagonist ketanserin were administered via an acute intraperitoneal injection to mice. Trace fear conditioning was measured as the amount of time spent immobile in the presence of the conditioned stimulus (CS, auditory tone), trace (silent interval) and post-trace interval over 10 trials. Extinction was determined by the number of trials required to resume mobility during CS, trace and post-trace when the shock was not delivered. Neurogenesis was determined by unbiased counts of cells in the dentate gyrus of the HPC birth-dated with BrdU co-expressing a neuronal marker. Mice treated with a range of doses of PSOP acquired a robust conditioned fear response. Mice injected with low doses of PSOP extinguished cued fear conditioning significantly more rapidly than high-dose PSOP or saline-treated mice. Injection of PSOP, 25I-NBMeO or ketanserin resulted in significant dose-dependent decreases in number of newborn neurons in hippocampus. At the low doses of PSOP that enhanced extinction, neurogenesis was not decreased, but rather tended toward an increase. Extinction of "fear conditioning" may be mediated by actions of the drugs at sites other than hippocampus such as the amygdala, which is known to mediate the perception of fear. Another caveat is that PSOP is not purely selective for 5-HT2A receptors. PSOP facilitates extinction of the classically conditioned fear response, and this, and similar agents, should be explored as potential treatments for post-traumatic stress disorder and related conditions.
Similar articles
-
Seo DO, Carillo MA, Chih-Hsiung Lim S, Tanaka KF, Drew MR. Seo DO, et al. J Neurosci. 2015 Aug 12;35(32):11330-45. doi: 10.1523/JNEUROSCI.0483-15.2015. J Neurosci. 2015. PMID: 26269640 Free PMC article.
-
Prazosin during fear conditioning facilitates subsequent extinction in male C57Bl/6N mice.
Lucas EK, Wu WC, Roman-Ortiz C, Clem RL. Lucas EK, et al. Psychopharmacology (Berl). 2019 Jan;236(1):273-279. doi: 10.1007/s00213-018-5001-x. Epub 2018 Aug 15. Psychopharmacology (Berl). 2019. PMID: 30112577 Free PMC article.
-
Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors.
Woodburn SC, Levitt CM, Koester AM, Kwan AC. Woodburn SC, et al. ACS Chem Neurosci. 2024 Aug 21;15(16):3034-3043. doi: 10.1021/acschemneuro.4c00279. Epub 2024 Aug 1. ACS Chem Neurosci. 2024. PMID: 39087917
-
Burghardt NS, Bauer EP. Burghardt NS, et al. Neuroscience. 2013 Sep 5;247:253-72. doi: 10.1016/j.neuroscience.2013.05.050. Epub 2013 Jun 1. Neuroscience. 2013. PMID: 23732229 Review.
-
Human fear conditioning and extinction in neuroimaging: a systematic review.
Sehlmeyer C, Schöning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, Konrad C. Sehlmeyer C, et al. PLoS One. 2009 Jun 10;4(6):e5865. doi: 10.1371/journal.pone.0005865. PLoS One. 2009. PMID: 19517024 Free PMC article. Review.
Cited by
-
Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ. Singewald N, et al. Pharmacol Ther. 2015 May;149:150-90. doi: 10.1016/j.pharmthera.2014.12.004. Epub 2014 Dec 27. Pharmacol Ther. 2015. PMID: 25550231 Free PMC article. Review.
-
Zhu L, Li L, Li XZ, Wang L. Zhu L, et al. Front Psychol. 2022 Jan 18;12:738211. doi: 10.3389/fpsyg.2021.738211. eCollection 2021. Front Psychol. 2022. PMID: 35153889 Free PMC article.
-
Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS. Pouyan N, et al. CNS Drugs. 2022 Oct;36(10):1031-1047. doi: 10.1007/s40263-022-00944-y. Epub 2022 Sep 12. CNS Drugs. 2022. PMID: 36097251 Free PMC article.
-
Xu S, Xu D, Wen L, Zhu C, Yang Y, Han S, Guan P. Xu S, et al. Drug Des Devel Ther. 2020 Sep 24;14:3899-3913. doi: 10.2147/DDDT.S270379. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33061296 Free PMC article.
-
Lysergic acid diethylamide: a drug of 'use'?
Das S, Barnwal P, Ramasamy A, Sen S, Mondal S. Das S, et al. Ther Adv Psychopharmacol. 2016 Jun;6(3):214-28. doi: 10.1177/2045125316640440. Epub 2016 Mar 23. Ther Adv Psychopharmacol. 2016. PMID: 27354909 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources